Moreover, miR‐660‐5p influences the proliferation, migration, invasion, and bone‐specific metastasis of human lung cancer cells through the miR‐660‐5p/SMARCA5/RANKL signaling pathways. Here, SMARCA5 is linked to lung carcinoma.